NCT03707951View on ClinicalTrials.gov

N-Acetylcysteine for Adolescent Alcohol Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

February 26, 2024

Study Completion Date

February 26, 2024

Conditions
Alcohol Use Disorder
Interventions
DRUG

N-acetylcysteine

N-acetylcysteine 1200 mg twice daily for 8 weeks (administered orally)

DRUG

Placebo oral capsule

Placebo (matched in appearance to N-acetylcysteine to preserve double-blind) twice daily for 12 weeks (administered orally)

Trial Locations (1)

29403

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03707951 - N-Acetylcysteine for Adolescent Alcohol Use Disorder | Biotech Hunter | Biotech Hunter